Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiko Nagayama

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
JMA Journal|August 10, 2023
Managing Seroma Formation Post Breast Surgery through Somatostatin AnalogsAiko Nagayama, Yuko Kitagawa
Oncology (Williston Park, N.Y.)|May 13, 2021
Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug ConjugatesAiko Nagayama, Neelima Vidula, Aditya Bardia
Therapeutic Advances in Medical Oncology|May 20, 2020
Novel antibody-drug conjugates for triple negative breast cancerAiko Nagayama, Neelima Vidula, Leif Ellisen, et al.
Targeted Oncology|November 9, 2017
Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest DevelopmentsAiko Nagayama, Leif W Ellisen, Bruce Chabner, et al.
Expert Opinion on Investigational Drugs|December 4, 2018
Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?Mark L Zangardi, Laura M Spring, Aiko Nagayama, et al.
Journal of the National Cancer Institute|March 6, 2015
ResponseAiko Nagayama, Tetsu Hayashida, Hiromitsu Jinno, et al.
Oncology Letters|September 26, 2017
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerAyako Nakashoji, Akira Matsui, Aiko Nagayama, et al.
Breast Cancer (Tokyo, Japan)|February 22, 2021
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulinXiaozhong Teng, Tetsu Hayashida, Takeshi Murata, et al.
Cancer Science|March 13, 2022
Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO systemTetsu Hayashida, Aiko Nagayama, Tomoko Seki, et al.
The Protein Journal|August 6, 2015
Nucleoside Diphosphate Kinase from Psychrophilic Pseudoalteromonas sp. AS-131 Isolated from Antarctic OceanYasushi Yonezawa, Aiko Nagayama, Hiroko Tokunaga, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
JMA Journal|August 10, 2023
Managing Seroma Formation Post Breast Surgery through Somatostatin AnalogsAiko Nagayama, Yuko Kitagawa
Oncology (Williston Park, N.Y.)|May 13, 2021
Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug ConjugatesAiko Nagayama, Neelima Vidula, Aditya Bardia
Therapeutic Advances in Medical Oncology|May 20, 2020
Novel antibody-drug conjugates for triple negative breast cancerAiko Nagayama, Neelima Vidula, Leif Ellisen, et al.
Targeted Oncology|November 9, 2017
Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest DevelopmentsAiko Nagayama, Leif W Ellisen, Bruce Chabner, et al.
Expert Opinion on Investigational Drugs|December 4, 2018
Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?Mark L Zangardi, Laura M Spring, Aiko Nagayama, et al.
Journal of the National Cancer Institute|March 6, 2015
ResponseAiko Nagayama, Tetsu Hayashida, Hiromitsu Jinno, et al.
Oncology Letters|September 26, 2017
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerAyako Nakashoji, Akira Matsui, Aiko Nagayama, et al.
Breast Cancer (Tokyo, Japan)|February 22, 2021
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulinXiaozhong Teng, Tetsu Hayashida, Takeshi Murata, et al.
Cancer Science|March 13, 2022
Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO systemTetsu Hayashida, Aiko Nagayama, Tomoko Seki, et al.
The Protein Journal|August 6, 2015
Nucleoside Diphosphate Kinase from Psychrophilic Pseudoalteromonas sp. AS-131 Isolated from Antarctic OceanYasushi Yonezawa, Aiko Nagayama, Hiroko Tokunaga, et al.
Pageof 4